Ibrahim, Ezzeldin <br/><br/>
Basal vs. luminal A breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  2009 
 - 372-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1357-0560 
<br/><br/><label>Standard No.: </label>10.1007/s12032-008-9131-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--classification<br/>Case-Control Studies<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Proportional Hazards Models<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism